BoMRA CEO Engages Key Veterinary Industry Stakeholders On New Medicines And Related Substances Act And Draft Regulations
The Chief Executive Officer of BoMRA, Dr Seima Dijeng, convened a meeting with a select group of key veterinary industry stakeholders to discuss the draft veterinary regulations under the new Medicines and Related Substances Act (MRSA). The engagement is part of a broader, ongoing stakeholder consultation on the Medicines and Related Substances Act (MRSA and […]